# Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

> **NCT04477616** · PHASE2 · COMPLETED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 160 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Day 7 regimen
- **DRUG:** Day 3 regimen

## Key facts

- **NCT ID:** NCT04477616
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-13
- **Primary completion:** 2022-10-06
- **Final completion:** 2022-11-06
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04477616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04477616, "Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04477616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*